| First-line Treatment With Camrelizumab + Apatinib Versus Chemotherapy + Bevacizumab in Advanced Cervical Cancer (NCT04974944) | Sun Yat-Sen University Cancer Center | 2021-07-30 |
| A Study of AK104, a PD-1/CTLA-4 Bispecific Antibody in Subjects With Recurrent/Metastatic Cervical Cancer (NCT04380805) | Akeso | 2020-07-15 |
| Cabozantinib Plus Pembrolizumab for Recurrent, Persistent and/or Metastatic Cervical Cancer (NCT04230954) | University of South Alabama | 2020-04-16 |
| Study of Anti-PD-1 Combined With Albumin-Bound Paclitaxel in Patients With Recurrent Cervical Cancer (NCT04341883) | Sun Yat-sen University | 2020-01-13 |
| Genetic Mutation in Recurrent Cervical Cancer (NCT04191226) | Lei Li | 2019-12-19 |
| Combination of Cryosurgey and NK Immunotherapy for Recurrent Cervical Cancer (NCT02849340) | Fuda Cancer Hospital, Guangzhou | 2016-07-01 |
| Family Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointestinal, Gynecologic, Urologic and Lung Cancers (NCT01846520) | City of Hope Medical Center | 2013-10-01 |
| Eribulin Mesylate in Treating Patients With Advanced or Recurrent Cervical Cancer (NCT01676818) | University of Southern California | 2012-08-09 |
| Carboplatin, Gemcitabine Hydrochloride, and Stereotactic Body Radiation Therapy in Gynecological Cancer (NCT01652794) | Case Comprehensive Cancer Center | 2012-05-01 |
| Stress Reduction in Improving Quality of Life in Patients With Recurrent Gynecologic or Breast Cancer (NCT01764789) | Ohio State University Comprehensive Cancer Center | 2010-10-01 |
| Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors (NCT01155258) | University of Southern California | 2010-06-01 |
| Triapine, Cisplatin, and Radiation Therapy in Treating Patients With Cervical Cancer or Vaginal Cancer (NCT00941070) | National Cancer Institute (NCI) | 2009-07-01 |
| Stereotactic Radiosurgery Using CyberKnife in Treating Women With Advanced or Recurrent Gynecological Malignancies (NCT01079832) | Case Comprehensive Cancer Center | 2009-05-01 |
| Sunitinib Malate in Treating Patients With Uterine Cervical Cancer That is Stage IVB, Recurrent, or Cannot Be Removed By Surgery (NCT00389974) | National Cancer Institute (NCI) | 2007-01-01 |
| Phase I Study of Intravenous Triapine (IND # 68338) in Combination With Pelvic Radiation Therapy With or Without Weekly Intravenous Cisplatin Chemotherapy for Locally Advanced Cervical, Vaginal, or Pelvic Gynecologic Malignancies (NCT00335998) | National Cancer Institute (NCI) | 2006-03-01 |
| Bevacizumab in Treating Patients With Persistent or Recurrent Cancer of the Cervix (NCT00025233) | National Cancer Institute (NCI) | 2002-04-01 |
| Erlotinib in Treating Patients With Persistent or Recurrent Cancer of the Cervix (NCT00031993) | National Cancer Institute (NCI) | 2002-03-01 |
| 7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007) (NCT00031681) | National Cancer Institute (NCI) | 2001-12-01 |
| Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction (NCT00030498) | National Cancer Institute (NCI) | 2001-12-01 |
| Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu (NCT00004074) | National Cancer Institute (NCI) | 1999-08-01 |
| Colposcopy and High Resolution Anoscopy in Screening For Anal Dysplasia in Patients With Cervical, Vaginal, or Vulvar Dysplasia or Cancer (NCT01313104) | Northwestern University | |